Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera immunomodulatory effects feasibility study using deuterated water
NL-OMON27762Recruiting
- Sponsor
- Not Applicable
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dimethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Not Applicable. Primary endpoints: Quantification of lymphocyte subset numbers over time, Production and disappearance rates of lymphocyte subsets and 1 more. Started Aug 2016; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON27762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27762.